Celera Using InforSense's Data Platform | GenomeWeb

NEW YORK (GenomeWeb News) – InforSense today said that it has "developed a long-term relationship" with Celera, under which the molecular diagnostics firm is using InforSense's Translational Research Solution in automating experimental data analysis and molecular annotation.

London-based InforSense said that it has provided Celera with a translation research platform that will support clinical data browsing, automated integration and analysis of enzyme-linked immunoassays, single nucleotide polymorphisms, and other experimental and public data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.